Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12,129 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Aspirin Is Related to Worse Clinical Outcomes of COVID-19.
Kim I, Yoon S, Kim M, Lee H, Park S, Kim W, Lee S. Kim I, et al. Among authors: kim w, kim m. Medicina (Kaunas). 2021 Sep 4;57(9):931. doi: 10.3390/medicina57090931. Medicina (Kaunas). 2021. PMID: 34577854 Free PMC article.
Risk Factors Affecting Breast Cancer-related Lymphedema: Serial Body Weight Change During Neoadjuvant Anthracycline Plus Cyclophosphamide Followed by Taxane.
Park S, Lee JE, Yu J, Paik HJ, Ryu JM, Kim I, Bae SY, Lee SK, Kim SW, Nam SJ, Kim EK, Kang E, Yang EJ. Park S, et al. Among authors: kim sw, kim ek, kim i. Clin Breast Cancer. 2018 Feb;18(1):e49-e54. doi: 10.1016/j.clbc.2017.06.003. Epub 2017 Jun 21. Clin Breast Cancer. 2018. PMID: 28705541 Free article.
The efficacy and safety of an indocyanine green-hyaluronic acid mixture (LuminoMark™) for localization in patients with non-palpable breast lesions: A multicenter, randomized, open-label, parallel phase 3 clinical trial.
Bang YJ, Choi HJ, Kim I, Lee MH, Lee S, Shin HJ, Nam SJ, Lee JE, Chae BJ, Lee SK, Ryu JM, Kim SW. Bang YJ, et al. Among authors: kim sw, kim i. Front Oncol. 2023 Mar 24;13:1039670. doi: 10.3389/fonc.2023.1039670. eCollection 2023. Front Oncol. 2023. PMID: 37035212 Free PMC article.
Prevalence and oncologic outcomes of BRCA 1/2 mutations in unselected triple-negative breast cancer patients in Korea.
Ryu JM, Choi HJ, Kim I, Nam SJ, Kim SW, Yu J, Lee SK, Choi DH, Park YH, Kim JW, Seo JS, Park JH, Lee JE, Kim SW; Korean Hereditary Breast Cancer Study Group. Ryu JM, et al. Among authors: kim sw, kim i, kim jw. Breast Cancer Res Treat. 2019 Jan;173(2):385-395. doi: 10.1007/s10549-018-5015-4. Epub 2018 Oct 22. Breast Cancer Res Treat. 2019. PMID: 30350268
12,129 results
You have reached the last available page of results. Please see the User Guide for more information.